Further Information
SPINT2, serine peptidase inhibitor, Kunitz type, 2, DIAR3, FLJ45571, HAI-2, HAI2, Kop, PB, hepatocyte growth factor activator inhibitor type 2, placental bikunin, serine protease inhibitor, Kunitz type, 2
Peptide ELISA: antibody detection limit dilution 1:16000.Western Blot:Approx 19kDa band observed in Human Placenta lysates (calculated MW of 21.8kDa according to NP_001159575.1). Recommended concentration: 0.3-1ug/ml. Primary incubation was 1 hour.Immunohistochemistry:Paraffin embedded Human Testis. Recommended concentration: 3.75ug/ml.
Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
Aliquot and store at -20?C. Minimize freezing and thawing.
500 ug/mL
Unconjugated
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
The immunogen for this antibody is: C-PSAPRRQDSEDH
10653
serine peptidase inhibitor, Kunitz type, 2
SPINT2
Homo sapiens
Liquid
NP_066925.1, NP_001159575.1
10863909
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Cancer
This antibody is expected to recognize both reported isoforms (NP_066925.1; NP_001159575.1).
O43291